---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-307795"
form_type: "8-K"
ticker: "ENGN"
cik: "0001980845"
company_name: "enGene Therapeutics Inc."
filed_at: "2026-07-17T20:05:21+00:00"
generated_at: "2026-07-17T20:07:10.512882+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# enGene updates corporate presentation; no specific financial or clinical details disclosed

## Summary
- Filed under Item 7.01; presentation furnished as Exhibit 99.1, not deemed filed.
- Presentation dated July 2026; content not provided in filing excerpt.
- No new material financial, clinical, or operational data available from this filing.
- Tickers: ENGN (common) and ENGNW (warrants) trade on Nasdaq.

## SEC filing metadata
- accession: 0001193125-26-307795
- form_type: 8-K
- ticker: ENGN
- cik: 0001980845
- company_name: enGene Therapeutics Inc.
- filed_at: 2026-07-17T20:05:21+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1980845/000119312526307795/0001193125-26-307795-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1980845/000119312526307795/engn-20260717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-307795
- JSON: https://secwatch.observer/filing/0001193125-26-307795.json
- Plain text: https://secwatch.observer/filing/0001193125-26-307795.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.